What's new in IDIS/Web:

 • New Drugs

 • Drug Term/Code Changes

 • Black Box Warnings

 • Advisory Committee Meetings

 • Priority Clinical Practice Guidelines

 

IDIS Training Tools

 

Stay Connected:

 • IDIS on Facebook

 • Join Our Update Lists

 • CAMIPR

 • Monthly Update Information

 

 

Email: idis@uiowa.edu


Drug Information Resources

IDIS Logo   IDIS Monthly Update Information - April 2011

NEW DRUG TERM
APREMILAST
APRICOXIB
AZD-1480
BMS-488043
CAL-101
CYT-387
ECHIUM
ITF-2357
LIPROTAMASE
LOSMAPIMOD
MK-0683
MLN-8054
MTRX-1011-A
NAVITOCLAX
PF-299804
PULPA DENTIS D-30
RVX-208
SB-1518
TG-101348
TOREZOLID
TRU-016
XL-019

CODE
44100106
28080611
10120970
8180896
10120964
10120969
92510279
10120968
56140024
14000077
10120967
10120973
82000545
10120972
10120963
34000012
24060052
10120971
10120966
8122952
10120965
10120974


DRUG TERM/CODE CHANGES

OLD TERM & CODENEW TERM & CODE
LBH-589 10120861PANOBINASTAT 10120861
RB-006 20120453PEGNIVACOGIN 20120453
RB-007 14000713ANIVAMERSEN 14000713


BLACK BOX WARNINGS

Article Number 653716: Revised (6/25/2010): Salmeterol: FDA Black Box Warning (IDIS Note: to View Outdated Warning See Article 555341). 2010.

Article Number 653715: Revised (6/13/2010): Mitoxantrone: FDA Black Box Warning (IDIS Note: to View Outdated Warning See Article 613773). 2010.

Article Number 653714: Revised (6/2/2010): Formoterol: FDA Black Box Warning (IDIS Note: to View Outdated Warning See Article 561302). 2010.

Article Number 653713: Revised (6/2/2010): Arformoterol: FDA Black Box Warning (IDIS Note: to View Outdated Warning See Article 577647). 2010.


FDA ADVISORY COMMITTEE MEETINGS

Article Numbers 653791-653801: Oncologic Drugs Advisory Committee Meeting, February 8, 2011. FDA Advisory Committee 2011.

Article Numbers 653784-653790: Peripheral and Central Nervous System Drugs Advisory Committee Meeting, March 10, 2011. FDA Advisory Committee 2011.

Article Numbers 653779-653783: Anesthetic and Life Support Drugs Advisory Committee Meeting, March 10, 2011. FDA Advisory Committee 2011.

Article Numbers 653707-653712: Gastrointestinal Drugs Advisory Committee Meeting, January 12, 2011. FDA Advisory Committee 2011.


PRIORITY CLINICAL PRACTICE GUIDELINES

Article Number 653706: Anonymous. NICE Technology Appraisal Guidance #216: Bendamustine for the First-Line Treatment of Chronic Lymphocytic Leukaemia. NICE Technol Appraisal Guid 2011.

Article Number 653705: Anonymous. NICE Technology Appraisal Guidance #215: Pazopanib for the First-Line Treatment of Advanced Renal Cell Carcinoma. NICE Technol Appraisal Guid 2011.

Article Number 653704: Anonymous. NICE Technology Appraisal Guidance #214: Bevacizumab in Combination with a Taxane for the First-Line Treatment of Metastatic Breast Cancer. NICE Technol Appraisal Guid 2011.

Article Number 653703: Anonymous. NICE Technology Appraisal Guidance #213: Aripiprazole for the Treatment of Schizophrenia in People Aged 15 to 17 Years. NICE Technol Appraisal Guid 2011.

Article Number 653699: Anonymous. Full Guideline. Alcohol-Use Disorders: Diagnosis, Assessment and Management of Harmful Drinking and Alcohol Dependence. NICE Clinical Guideline No. 115 (Ref Art 653699-653702). NICE Clin Guidel 2011.

Article Number 653695: Anonymous. Full Guideline. Anaemia Management in People with Chronic Kidney Disease. NICE Clinical Guideline No. 114 (Ref Art 653695-653698). NICE Clin Guidel 2011.

Article Number 653691: Anonymous. Full Guideline. Generalised Anxiety Disorder and Panic Disorder (With or Without Agoraphobia) in Adults: Management in Primary, Secondary and Community Care. NICE Clinical Guideline No. 113 (Ref Art 653691-653694). NICE Clin Guidel 2011.

Article Number 652911: Kris M G, Benowitz S I, Adams S, Diller L, et al. Clinical Cancer Advances 2010: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology (Erratum) (Art 649850). J Clin Oncol 2011, 29:947.


College of Pharmacy